Helius Medical Technologies, Inc. announces impairment charges for the three months ended September 30 2023. For the quarter, the company reported Goodwill and fixed asset impairment of $159,000 against $757,000 a year ago.
Helius Medical Technologies, Inc.
Equities
HSDT
US42328V8019
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.09 USD | -9.11% | -19.41% | -49.12% |
Apr. 24 | Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center | CI |
Apr. 03 | Top Premarket Gainers | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.12% | 11M | |
+8.69% | 220B | |
+6.69% | 183B | |
+10.90% | 133B | |
+25.41% | 107B | |
-0.19% | 63.05B | |
+12.72% | 51.74B | |
+3.96% | 50.47B | |
+0.40% | 40.91B | |
+15.03% | 40.59B |
- Stock Market
- Equities
- HSDT Stock
- News Helius Medical Technologies, Inc.
- Helius Medical Technologies, Inc. Announces Impairment Charges for the Three Months Ended September 30 2023